TABLE 1.

FDA-Approved Rituximab Indications⁷

Indication	FDA Approval Date	Orphan Designation
Non-Hodgkin B-cell lymphoma	11/26/1997	Yes
Wegener granulomatosis	4/19/2011	Yes
Microscopic polyangiitis	4/19/2011	Yes
Chronic lymphocytic leukemia	6/22/2017	Yes
Pemphigus vulgaris	6/7/2018	Yes
Immune thrombocytopenia purpura	–	Yes
Churg-Strauss syndrome	–	Yes
Rasmussen encephalitis	–	Yes
Rheumatoid arthritis	2/28/2006	No

FDA = U.S. Food and Drug Administration.